Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases

NARecruitingINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

September 18, 2025

Primary Completion Date

September 18, 2027

Study Completion Date

September 18, 2028

Conditions
Crohn DiseaseUlcerative Colitis
Interventions
DEVICE

MedicWise

"* Both arms are equipped with the application, data are collected via the application and telemonitoring with alerts to the care team are activated in the active telemonitoring arm.~* Data are collected in both arms at baseline, M3, M6, M9 and M12~* Each center defines who handles alerts internally (physicians, IBD nurses, others, etc.) according to its internal organization. The application does not impose an internal operation.~* the alert thresholds are identical and fixed for all centers during the study. Within the framework of the study, alerts are defined according to the study's modalities but cannot be modified by the centers.~* Participating sites will have no obligation to respond to alerts.~* Randomization will be stratified by centers and by diseases (Crohn and UC) with unbalanced blocks of randomization"

Trial Locations (1)

92200

RECRUITING

Institut des MICI, Neuilly-sur-Seine

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

collaborator

Semeia

INDUSTRY

lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER